Cell & Gene Therapy

Exploring the latest news and insight around cell and gene therapy, including new technology and information on treatments. See how pharma is leveraging gene therapy and cell therapy to prevent and treat disease.

Biotech

Cellectis cans allogeneic CAR-Ts to hop aboard in vivo bandwagon

Cellectis kicked off 2026 promising “huge momentum” for its allogeneic CAR-Ts, but the biotech was unable to resist the dominance of in vivo options.

James Waldron Sep 14, 2026 5:26am

denovirus transmission replication treatments 3D scientific illustration

Encoded executes $275M series F to advance Dravet drug

Sep 9, 2026 9:42am

BMS’ pivotal CAR-T multiple myeloma trial hits primary endpoint

Sep 8, 2026 9:11am

layoffs cuts workforce reduction chairs boxes fired

TScan axes 75% of staff to make room for solid tumor programs

Sep 2, 2026 10:46am

ArsenalBio sheds most of staff in pivot to in vivo CAR-T

Sep 1, 2026 9:59am

Stop sign and red lights at traffic intersection

Novartis halts autoimmune CAR-T trials after 3 deaths

Aug 31, 2026 6:25pm